HC Wainwright Reiterates Buy Rating for Dynavax Technologies (NASDAQ:DVAX)
Dynavax Technologies (NASDAQ:DVAX – Get Free Report)‘s stock had its “buy” rating reiterated by HC Wainwright in a report released on Wednesday, Benzinga reports. They currently have a $29.00 target price on the biopharmaceutical company’s stock. HC Wainwright’s target price would indicate a potential upside of 163.64% from the stock’s previous close. HC Wainwright also […]
More Stories
Knowles (NYSE:KN) Updates Q3 2024 Earnings Guidance
Knowles (NYSE:KN – Get Free Report) issued an update on its third quarter 2024 earnings guidance on Thursday morning. The...
Fidelity Disruptive Finance ETF (FDFF) To Go Ex-Dividend on September 20th
Fidelity Disruptive Finance ETF (NASDAQ:FDFF – Get Free Report) declared a quarterly dividend on Thursday, September 19th, NASDAQ reports. Shareholders...
Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Misses Expectations By $0.14 EPS
Rezolute (NASDAQ:RZLT – Get Free Report) posted its earnings results on Thursday. The company reported ($0.44) earnings per share (EPS)...
MillerKnoll (NASDAQ:MLKN) Issues FY25 Earnings Guidance
MillerKnoll (NASDAQ:MLKN – Get Free Report) issued an update on its FY25 earnings guidance on Thursday morning. The company provided...
Lennar (NYSE:LEN) Updates Q4 2024 Earnings Guidance
Lennar (NYSE:LEN – Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Friday morning. The...
Insider Selling: Rent the Runway, Inc. (NASDAQ:RENT) Insider Sells $13,940.00 in Stock
Rent the Runway, Inc. (NASDAQ:RENT – Get Free Report) insider Sarah K. Tam sold 1,394 shares of the stock in...